Sinopharm Group Co. Ltd. (SHTDY) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Sinopharm Group Co. Ltd.

    OTC: SHTDY · Real-Time Price · USD
    11.97
    0.00 (0.03%)
    At close: Oct 03, 2025, 3:58 PM
    11.97
    -0.03%
    After-hours: Oct 01, 2025, 08:00 PM EDT

    Sinopharm Cash Flow Statement

    Financials in CNY. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2025 Q4 2024 Q2 2024 Q4 2023 Q2 2023 Q4 2022 Q2 2022 Q4 2021 Q2 2021
    Period Ending Jun 30, 2025 Dec 31, 2024 Jun 30, 2024 Dec 31, 2023 Jun 30, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021
    Net Income
    		 6.8B 7.05B 8.65B 9.05B 4.1B 3.69B 7.87B 7.76B 7.87B
    Depreciation & Amortization
    		 4.64B 4.73B 4.64B 4.41B 2.1B 2B 3.9B 3.78B 3.76B
    Stock-Based Compensation
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Other Working Capital
    		 -5.46B n/a 3.42B 3.71B 5.74B -3.31B -2.28B 421.26M 2.33B
    Other Non-Cash Items
    		 -54.38B -237.37M 6.38B 14.4B 77.62B 64.24B 20.8B 28.41B 35.06B
    Deferred Income Tax
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Change in Working Capital
    		 61.37B n/a -164.16M -10.69B -71.89B -48.97B -29.79B -30.64B -35.71B
    Operating Cash Flow
    		 18.43B 11.55B 19.51B 17.17B 11.93B 20.96B 2.78B 9.31B 10.98B
    Capital Expenditures
    		 -2.11B -2.46B -2.26B -1.96B -1.66B -1.82B -2.15B -2.07B -2.1B
    Cash Acquisitions
    		 102.01M n/a -59.47M 16.62M -259.22M -396.37M -426.99M -497.22M -2.19B
    Purchase of Investments
    		 n/a n/a 61.51M 61.51M 78.46M 78.46M n/a n/a n/a
    Sales Maturities Of Investments
    		 n/a n/a -150.49M -150.49M -63.84M -63.84M n/a n/a n/a
    Other Investing Acitivies
    		 -1.24B -1.29B -164.45M 1.67B 321.81M -179.79M 1.61B 1.3B 186.01M
    Investing Cash Flow
    		 -3.24B -3.75B -2B 223.09M -1.39B -2.18B -964.24M -1.27B -4.11B
    Debt Repayment
    		 18.71B 23.87B -1.31B -25.18B -15.61B -15.61B n/a n/a n/a
    Common Stock Repurchased
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Dividend Paid
    		 -4.86B -5.06B -4.9B -2.56B n/a n/a -2.15B -2.15B -1.86B
    Other Financial Acitivies
    		 -37.11B -36.1B -1.18B 20.09B 13.49B 14.71B -1.89B -12.54B -9.99B
    Financial Cash Flow
    		 -23.26B -17.29B -7.39B -7.64B -2.11B -894.83M -4.04B -14.69B -11.85B
    Net Cash Flow
    		 -8.09B n/a 73.88B 9.7B 5.55B 15.01B -2.21B -6.65B -4.96B
    Free Cash Flow
    		 16.32B 9.09B 17.24B 15.21B 7.4B 16.28B 631.03M 7.23B 8.88B

    Add to Watchlist